Bliss GVS Pharma Limited — Others, 13-05-2025: Copy of Newspaper Publication

Bliss GVS Pharma Ltd. has announced a board meeting to approve issuing sweat equity shares to its Vice-President and Managing Director, aiming to align management’s interests with shareholders. The company is conducting a postal ballot with remote e-voting for shareholder approval, ensuring transparency through a designated scrutinizer. Voting results will be shared with stock exchanges and made publicly available, reflecting the company’s commitment to incentivizing key personnel and supporting long-term value creation.